Biodexa Pharmaceuticals Plc (BDRX)
USD 1.4
(-0.71%)
USD 1.4
(-0.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 381 Thousand | 699 Thousand | 578 Thousand | 343 Thousand | 674 Thousand | 1.93 Million |
| Cost of Revenue | 4.06 Million | 5.11 Million | 4.65 Million | 6.06 Million | 7.84 Million | 9.35 Million |
| Gross Profit | -3.68 Million | -4.41 Million | -4.07 Million | -5.72 Million | -7.16 Million | -7.42 Million |
| Operating Expenses | 4.32 Million | 4.05 Million | 1.98 Million | 17.71 Million | 3.66 Million | 4.39 Million |
| Selling, General and Administrative Expenses | 4.34 Million | 4.54 Million | 2.94 Million | 4.95 Million | 4.16 Million | 4.39 Million |
| Research and Development Expenses | 4.06 Million | 5.11 Million | 4.65 Million | 16.14 Million | 7.84 Million | 9.35 Million |
| Other Expenses | -4.08 Million | - | - | - | - | - |
| Cost and Expenses | 8.39 Million | 9.16 Million | 6.64 Million | 23.77 Million | 11.5 Million | 13.75 Million |
| Operating Income | -8.01 Million | -8.93 Million | -6.99 Million | -10.67 Million | -11.31 Million | -11.81 Million |
| Interest Expense | 41 Thousand | 53 Thousand | 44 Thousand | 34 Thousand | 97 Thousand | 587 Thousand |
| Income Tax Expense | -406 Thousand | 832 Thousand | 646 Thousand | 1.28 Million | 1.78 Million | 2.03 Million |
| Earnings before Tax | -7.48 Million | -8.48 Million | -6.1 Million | -23.47 Million | -10.92 Million | -12.4 Million |
| Net Income | -7.07 Million | -7.65 Million | -5.46 Million | -22.18 Million | -9.13 Million | -10.36 Million |
| Earnings Per Share Basic | -224.13 | -619.72 | -542.31 | -4143.60 | -3988.65 | - |
| Earnings Per Share Diluted | -224.13 | -619.72 | -542.31 | -4143.60 | -3988.65 | - |
| Weighted Average Shares Outstanding | 31.58 Thousand | 12.35 Thousand | 10.06 Thousand | 5355.00 | 2291.00 | - |
| Weighted Average Shares Outstanding (Diluted) | 31.58 Thousand | 12.35 Thousand | 10.06 Thousand | 5355.00 | 2291.00 | - |
| Gross Margin | -9.67 | -6.31 | -7.05 | -16.69 | -10.64 | -3.83 |
| EBIT Margin | -16.95 | -12.53 | -11.74 | -27.91 | -15.34 | -5.52 |
| Profit Margin | -18.58 | -10.95 | -9.45 | -64.69 | -13.56 | -5.35 |
| EBITDA | -6.45 Million | -7.39 Million | -5.65 Million | -22.21 Million | -9.54 Million | -10.7 Million |
| Earnings Before Tax Margin | -21.03 | -12.78 | -12.11 | -31.11 | -16.79 | -6.10 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 41.5 Thousand | 381 Thousand | 41.5 Thousand | 149 Thousand |
| Cost of Revenue | 1.09 Million | 1.09 Million | 1.12 Million | 4.06 Million | 1.12 Million | 1.12 Million |
| Gross Profit | -1.09 Million | -1.09 Million | -1.08 Million | -3.68 Million | -1.08 Million | -976.5 Thousand |
| Operating Expenses | 1.01 Million | 1.01 Million | 801 Thousand | 4.32 Million | 3 Million | 952.49 Thousand |
| Selling, General and Administrative Expenses | 1.01 Million | 1.01 Million | 370.5 Thousand | - | 370.5 Thousand | 1.14 Million |
| Research and Development Expenses | 1.09 Million | 1.09 Million | 908 Thousand | - | 908 Thousand | 1.12 Million |
| Other Expenses | -1.09 Million | -1.09 Million | -477.5 Thousand | - | - | - |
| Cost and Expenses | 2.11 Million | 2.11 Million | 1.92 Million | 8.39 Million | 4.12 Million | 2.07 Million |
| Operating Income | -2.11 Million | -2.11 Million | -1.88 Million | -8.01 Million | -1.18 Million | -2.12 Million |
| Interest Expense | - | - | - | 41 Thousand | - | - |
| Income Tax Expense | 62.5 Thousand | 62.5 Thousand | 59 Thousand | -406 Thousand | 59 Thousand | 144 Thousand |
| Earnings before Tax | -1.71 Million | -1.71 Million | -1.81 Million | -7.48 Million | -1.81 Million | -1.92 Million |
| Net Income | -1.65 Million | -1.65 Million | -1.75 Million | -7.07 Million | -1.75 Million | -1.78 Million |
| Earnings Per Share Basic | -5.04 | -5.04 | -32.97 | - | -1.32 | -7.19 |
| Earnings Per Share Diluted | -5.04 | -5.04 | -32.97 | - | -1.32 | -7.19 |
| Weighted Average Shares Outstanding | 328.08 Thousand | 328.08 Thousand | 53.25 Thousand | 789.62 Thousand | 1.33 Million | 247.97 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 328.08 Thousand | 328.08 Thousand | 53.25 Thousand | 789.62 Thousand | 1.33 Million | 247.97 Thousand |
| Gross Margin | - | - | -26.12 | -9.67 | -26.12 | -6.55 |
| EBIT Margin | - | - | -27.55 | - | -27.55 | -14.00 |
| Profit Margin | - | - | -42.30 | -18.58 | -42.30 | -11.97 |
| EBITDA | -2.07 Million | -2.07 Million | -1.14 Million | - | -1.14 Million | -2.08 Million |
| Earnings Before Tax Margin | - | - | -45.42 | -21.03 | -28.43 | -14.24 |
CBIT
SBKFF
TPB
MOV
CULL
HLTRF